Syneos Health announced late Monday afternoon that its CFO Jason Meggs will leave the company to pursue other career opportunities.

The 2022 MM+M Agency 100 honoree has retained an executive search firm to look for its next CFO. Beggs has agreed to serve as a consultant and support Syneos Health’s “ongoing transformation” through the end of 2023.

“I am grateful for having had the opportunity to work alongside my talented Syneos Health colleagues, and I am proud of our team’s many accomplishments. I am committed to supporting the finance team to ensure a smooth transition,” Meggs said in a statement.

The company also announced that it is reaffirming its estimated full-year 2022 revenue guidance and noted that Beggs’ pending departure is not “a result of any disagreement regarding the company’s financial statements or disclosures.”

“Jason has been an integral member of the Executive Leadership Team over the past five years, and, on behalf of the entire Company, I would like to thank him for his many contributions to Syneos Health,” Syneos Health CEO Michelle Keefe said in a statement. “I believe our balance sheet, strategy, and integrated expertise position us well to manage near-term headwinds while we continue to make investments for the Company’s long-term success.”

This is the latest personnel move for Syneos, which saw its global president Tim Pantello bolt for the top spot at Relevate Health in October. Weeks later, the company brought William E. Klitgaard back as an independent director.

Syneos Health announced the Meggs news hours before unveiling its Dealmakers’ Intentions Survey, which found that biopharma companies are “optimistic” for M&A and licensing deals this year. Still, the report indicated that pharma companies remain cautious about pursuing deals, though M&A activity could pick up during the second half of 2023.

Syneos certainly has not been resting during a volatile macroeconomic cycle, acquiring Boco Digital Health, a training and development company, in mid-August. 

Additionally, the company released a report last month that outlined 12 key trends for medical marketers to keep on their radar in the new year across three categories: technology evolution, human engagement and healthcare advancement.